EVOTF News and Press, Evotec Ag Ord From 02/09/23

EVOTEC AND RELATED SCIENCES COLLABORATE BY COMBINING COMPLEMENTARY CAPABILITIES TO ADVANCE PORTFOLIOS OF TRANSFORMATIONAL NEW MEDICINES THE PARTNERSHIP OVERSEES A GROWING PORTFOLIO OF MORE THAN 15 MULTI-MODALITY DRUG DISCOVERY PROGRAMMES EXTENSION AND EXPANSION THROUGH 2030 TO INCLUDE E...

HAMBURG, GERMANY / ACCESSWIRE / February 7, 2023 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company's Supervisory Board has appointed Laetitia Rouxel as new Chief Financial Officer and member of the Management Board effective...

STRATEGIC PARTNERSHIP LEVERAGES EVOTEC'S EXPERTISE & INTEGRATED PLATFORM FOR DISCOVERY AND DEVELOPMENT HAMBURG, GERMANY / ACCESSWIRE / January 26, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has entered in...

Summary The Seeking Alpha Quant system has its quirks, but it is a great tool to find holdings. I will discuss the performance of the five holdings I covered in the prior article. Also, at the end, I will provide some interesting literature discussing the Seeking Alpha platform as a...

Evotec SE (EVOTF) Q3 2022 Results Conference Call November 09, 2022 08:00 AM ET Company Participants Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Craig Johnstone - Chief Operating Officer Cord Dohrmann - Chief Scientific ...

Evotec SE press release ( OTCPK:EVOTF ): Q3 adjusted Group EBITDA totalled €44.6M (9M 2021: €70.1M) Revenue of €510.8M (+18.5% Y/Y). Outlook for FY2022 unchanged and mid-term targets 2025 confirmed : Group revenues expected to be in a range of...

Evotec SE (EVOTF) Q2 2022 Earnings Conference Call August 11, 2022, 8:00 AM ET Company Participants Dr. Werner Lanthaler - Chief Executive Officer Enno Spillner - Chief Financial Officer Cord Dohrmann - Chief Scientific Officer Craig Johnstone - Chief Operati...

The following slide deck was published by Evotec SE in conjunction with their 2022 Q2 earnings call. For further details see: Evotec SE 2022 Q2 - Results - Earnings Call Presentation

Evotec ( NASDAQ: EVO ) said its Seattle-based unit Just - Evotec Biologics expanded a multi-year partnership with Alpine Immune Sciences ( NASDAQ: ALPN ) to develop a commercial process for ALPN-303. Evotec said ALPN-303 is being developed t...

When Evolution (Evo) does $100 in sales, after all costs and taxes more than $60 land in the owner’s pockets. In June, Evo committed EUR 340m cash to acquire top-quality online slot provider Nolimit City, which is expected to achieve EBITDA margins even higher than Evo. EVV...